On the heels of a year that saw a record amount of venture cash flow into healthcare startups, investor appetite for healthtech does not appear to be waning.
These 2021 30 Under 30 listmakers from the science and healthcare lists have devoted time, energy, and countless research hours to helping solve the Covid-19 crisis
By betting on a subscription business model and targeting niche groups like expectant moms and teen girls, can this former venture partner crack the $36 billion vitamin and supplement industry?
Amid a pandemic implosion, these startups showcase the strength, diversity and adaptability of America’s entrepreneurs—and provide hope for the country’s economic future.
Biotech company Mammoth Biosciences has signed an exclusive deal with University of California Berkeley to license a newly-discovered class of Crispr proteins.